BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 26800433)

  • 1. Measurement of liver iron concentration by superconducting quantum interference device biomagnetic liver susceptometry validates serum ferritin as prognostic parameter for allogeneic stem cell transplantation.
    Jacobi N; Herich L
    Eur J Haematol; 2016 Oct; 97(4):336-41. PubMed ID: 26800433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
    Busca A; Falda M; Manzini P; D'Antico S; Valfrè A; Locatelli F; Calabrese R; Chiappella A; D'Ardia S; Longo F; Piga A
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI-based liver iron content predicts for nonrelapse mortality in MDS and AML patients undergoing allogeneic stem cell transplantation.
    Wermke M; Schmidt A; Middeke JM; Sockel K; von Bonin M; Schönefeldt C; Mair S; Plodeck V; Laniado M; Weiss G; Schetelig J; Ehninger G; Theurl I; Bornhäuser M; Platzbecker U
    Clin Cancer Res; 2012 Dec; 18(23):6460-8. PubMed ID: 22991415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation.
    Lim ZY; Fiaccadori V; Gandhi S; Hayden J; Kenyon M; Ireland R; Marsh J; Ho AY; Mufti GJ; Pagliuca A
    Leuk Res; 2010 Jun; 34(6):723-7. PubMed ID: 19944463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum ferritin is not a reliable predictor to determine iron overload in thalassemia major patients post-hematopoietic stem cell transplantation.
    Jarisch A; Salzmann-Manrique E; Cario H; Grosse R; Soerensen J; Fischer R; Schulz A; Hammerstingl R; Wunderlich A; Bader P
    Eur J Haematol; 2018 Dec; 101(6):791-797. PubMed ID: 30187571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of serum ferritin values by magnetic susceptometry in predicting iron overload in dialysis patients.
    Canavese C; Bergamo D; Ciccone G; Longo F; Fop F; Thea A; Martina G; Piga A
    Kidney Int; 2004 Mar; 65(3):1091-8. PubMed ID: 14871430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of pretransplant iron overload measured with magnetic resonance imaging on severe infections in allogeneic stem cell transplantation.
    Virtanen JM; Itälä-Remes MA; Remes KJ; Vahlberg T; Saunavaara JP; Sinisalo M; Parkkola RK
    Eur J Haematol; 2013 Jul; 91(1):85-93. PubMed ID: 23586843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI-based quantitative susceptibility mapping (QSM) and R2* mapping of liver iron overload: Comparison with SQUID-based biomagnetic liver susceptometry.
    Sharma SD; Fischer R; Schoennagel BP; Nielsen P; Kooijman H; Yamamura J; Adam G; Bannas P; Hernando D; Reeder SB
    Magn Reson Med; 2017 Jul; 78(1):264-270. PubMed ID: 27509836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of non-transferrin-bound iron (NTBI) in comparison to serum ferritin on outcome after allogeneic stem cell transplantation (ASCT).
    Hilken A; Langebrake C; Wolschke C; Kersten JF; Rohde H; Nielsen P; Kröger N
    Ann Hematol; 2017 Aug; 96(8):1379-1388. PubMed ID: 28585071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron overload: predictor of adverse outcome in hematopoietic stem cell transplantation.
    Sucak GT; Yegin ZA; Ozkurt ZN; Aki SZ; Yağci M
    Transplant Proc; 2010 Jun; 42(5):1841-8. PubMed ID: 20620535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Bone Marrow Iron Scores Are Strongly Correlated With Elevated Serum Ferritin Levels and Poorer Survival in Patients With Iron Overload That Underwent Allogeneic Hematopoietic Stem Cell Transplantation: A Single Center Experience.
    Sivgin S; Nazlim S; Zararsiz G; Baspinar O; Kaynar L; Deniz K; Cetin M; Unal A; Eser B
    Clin Lymphoma Myeloma Leuk; 2016 Oct; 16(10):582-587. PubMed ID: 27769559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between Plasma Endothelin-1, Transforming Growth Factor-β, Fibroblast Growth Factor, and Nitric Oxide Levels and Liver Injury in Hematopoietic Stem Cell Transplantation Recipients with Persistent Iron Overload after Transplantation.
    Akı ŞZ; Suyanı E; Cengiz M; Özenirler S; Elbeğ Ş; Paşaoğlu H; Sucak GT
    Biol Blood Marrow Transplant; 2015 May; 21(5):948-53. PubMed ID: 25681034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Hepatic Iron Content Predicts Poor Survival in Patients With Iron Overload Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation.
    Sivgin S; Baldane S; Deniz K; Zararsiz G; Kaynar L; Cetin M; Unal A; Eser B
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S10-8. PubMed ID: 27521305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI as an alternative to serum ferritin for diagnosis of iron overload in children in the context of immune response after stem cell transplantation.
    Wurschi GW; Mentzel HJ; Herrmann KH; Krumbein I; Beck JF; Reichenbach JR; Kentouche K
    Pediatr Transplant; 2019 Dec; 23(8):e13583. PubMed ID: 31535426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-transplantation serum ferritin as a prognostic marker in allogeneic haemopoietic stem cell transplant patients in a tertiary care hospital in Malaysia.
    Thambiah SC; George E; Samsudin IN; Hong LH; Chuo LL; Ramli N; Zakaria MZ
    Natl Med J India; 2016; 29(3):136-140. PubMed ID: 27808061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Room-temperature susceptometry predicts biopsy-determined hepatic iron in patients with elevated serum ferritin.
    Maliken BD; Avrin WF; Nelson JE; Mooney J; Kumar S; Kowdley KV
    Ann Hepatol; 2012; 11(1):77-84. PubMed ID: 22166564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients.
    Pakbaz Z; Fischer R; Fung E; Nielsen P; Harmatz P; Vichinsky E
    Pediatr Blood Cancer; 2007 Sep; 49(3):329-32. PubMed ID: 17554789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
    Chirico V; Rigoli L; Lacquaniti A; Salpietro V; Piraino B; Amorini M; Salpietro C; Arrigo T
    Eur J Haematol; 2015 May; 94(5):404-12. PubMed ID: 25200112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors.
    Majhail NS; DeFor T; Lazarus HM; Burns LJ
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):790-4. PubMed ID: 18541198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of iron chelation therapy on patients with lower/intermediate IPSS MDS and the prognostic role of elevated serum ferritin in patients with MDS and AML: A meta-analysis.
    Yang Y; Tang Z; An T; Zhao L
    Medicine (Baltimore); 2019 Oct; 98(40):e17406. PubMed ID: 31577751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.